Results 101 to 110 of about 12,380 (194)

Prasugrel in the Elderly [PDF]

Circulation, 2018
openaire   +2 more sources

Prasugrel versus ticagrelor in patients with Acute Coronary syndrome treated with percutaneous coronary intervention

, 2018
Background: No association studies for the efficacy and safety of ticagrelor vs. prasugrel have been published in India. Aim of the study was to compare the safety and efficacy of Prasugrel versus Ticagrelor in Patients with Acute Coronary Syndrome ...
Jamwal, Naveen, Shiv Shanker Tripathi, Tripathi, Shiv Shanker, Naveen Jamwal   +3 more
core   +2 more sources

Prasugrel [PDF]

Reactions Weekly, 2020
openaire   +2 more sources

Ticagrelor Versus Prasugrel in Acute Coronary Syndrome: Real-World Treatment and Safety

Medicines
Introduction: A direct head-to-head comparison between potent P2Y12 inhibitors: prasugrel versus ticagrelor is still lacking. Purpose: In this single-center study, we sought to address the efficacy and safety of these two third-generation antiplatelet ...
Fadel Bahouth, Boris Chutko, Haitham Sholy, Sabreen Hassanain, Gassan Zaid, Evgeny Radzishevsky, Ibrahem Fahmwai, Mahmod Hamoud, Nemer Samnia, Johad Khoury, Idit Dobrecky-Mery   +10 more
doaj   +1 more source

Antiplatelet efficacy of prasugrel in patients with high on-clopidogrel treatment platelet reactivity and a history of coronary stenting.

, 2013
Little is known about the antiplatelet action of the 3 rd generation thienopyridine prasugrel in patients showing high platelet reactivity (PR) levels on clopidogrel.
Bernlochner, Isabell;Mayer, Katharina;Morath, Tanja;Orban, Martin;Schulz, Stefanie;Schömig, Albert;Braun, Siegmund;Kastrati, Adnan;Sibbing, Dirk
core   +1 more source

Comparison of prasugrel and clopidogrel-treated patients with acute coronary syndrome undergoing percutaneous coronary intervention: A propensity score-matched analysis of the Acute Myocardial Infarction in Switzerland (AMIS)-Plus Registry

, 2016
OBJECTIVE The purpose of this study was to investigate outcomes of patients treated with prasugrel or clopidogrel after percutaneous coronary intervention (PCI) in a nationwide acute coronary syndrome (ACS) registry.
Roffi, Marco, Pedrazzini, Giovanni, Windecker, Stephan, Kurz, David J, Radovanovic, Dragana, Seifert, Burkhardt, Erne, Paul, Bernheim, Alain M, Eberli, Franz R   +8 more
core   +1 more source

Association of Clopidogrel with Interstitial Lung Disease: Gaining Insight Through the Japanese Pharmacovigilance Database

Vascular Health and Risk Management
Mariko Kozaru, Hiroko Kambara, Akari Higuchi, Tatsuki Kagatsume, Keiko Hosohata Education and Research Center for Clinical Pharmacy, Faculty of Pharmacy, Osaka Medical and Pharmaceutical University, Takatsuki, Osaka, 569-1094, JapanCorrespondence: Keiko ...
Kozaru M, Kambara H, Higuchi A, Kagatsume T, Hosohata K   +4 more
doaj  

2025 Acute Coronary Syndrome Guideline: Missing the Boat on <i>CYP2C19</i> Genotyping. [PDF]

J Am Heart Assoc
Cavallari LH, Lee CR, Beitelshees AL, Luzum JA, Stouffer GA, Ten Berg JM, van den Broek WWA, Pereira NL, Sibbing D, Angiolillo DJ.   +9 more
europepmc   +1 more source

Acquired Hemophilia A During Prasugrel Therapy After Recurrent Acute Coronary Syndrome. [PDF]

JACC Case Rep
Yao S, Fujisawa N, Otsuka K, Nagasaki J, Kawase T, Takahashi Y, Fukuda D.   +6 more
europepmc   +1 more source

Toward Optimal Antiplatelet Therapy in Acute Ischemic Stroke: What Can We Learn from a Post Hoc Subgroup Analysis of the ACUTE-PRAS Study? [PDF]

J Atheroscler Thromb
Wakisaka Y, Ago T.
europepmc   +1 more source